VIDEOS & MORE
2022 Medicon Valley Microbiome Pitch Day
Back Bay’s Peter Bak gave the keynote presentation at the 2022 Medicon Valley Microbiome Pitch Day, a unique event that showcased startups in the human microbiome field looking for collaboration or investment with regional, national or international partners.
Medicon Valley Microbiome Pitch Day was a prime opportunity to attract capital or funding, meet potential partners, and tap into early-stage startups.
Preparing for and Executing Successful Cross-Border Transactions
Life sciences is a global industry, and cross-border deals are often critical for growth and internationalization plans. Scientific, market, structural, and cultural challenges are all key considerations in successful licensing, partnering or M&A deal across borders.
Building Successful International Medtech – Investment, Planning and US Market Access
September 20, 2021 - Life sciences is a global industry and cross-border deals are often critical for growth and internationalisation plans. Scientific, market, structural and cultural challenges are all key considerations in successful licencing, partnering or M&A deal across borders.
Global Insights from Investors, Bankers & Strategic Advisors on Taking Your BioPharma or MedTech Company to the Next Level
Back Bay Life Science Advisors and The Life Science Cluster, Norway presented a forum on life sciences development. Global life science strategists, bankers, lawyers and investors shared top challenges, common pitfalls, and potential economic opportunities typically seen for emerging companies looking to reach sizable pharma-scale development on the global stage.
With insights from Shearman & Sterling, BioVentures MedTech Funds, Flare Capital, Caladrius Biosciences and Back Bay Life Science Advisors investment banking and strategy teams.
DKBIO May 2021
The Innovation Centre Denmark, Boston, and Back Bay Life Science Advisors hosted a forum on taking Nordic biopharma and medtech companies to the international stage.
The forum covered steps to successful entry to the global market, including:
Understanding the target ecosystem and its gaps
Articulating the ability to meet a global need while respecting different corporate cultures
Building a strategic scientific advisory global board.
The forum includes:
A CEO Fireside Chat with Jonathan P. Gertler, Back Bay Life Science Advisors and Rahul Kakkar, Pandion Therapeutics
Discussion with experts from UCB Pharma, Lundbeckfonden Ventures, Inthera Bioscience, Eli Lilly and Company, and Back Bay’s investment banking and strategy teams.
Preparing Norwegian BioPharma and MedTech Companies for Investor Meetings, Norway
Preparing for investor meetings is vital for successful life science companies. So what happens after the investor is interested and starts a formal process to analyze your business case? How can you best prepare and position to gain investor interest and potential funding?
Join Norway’s Life Science Cluster, with experts from Sarsia Seed, Arxx Therapeutics, Back Bay Life Science Advisors, and others for insight and investor partnering.
Emerging BioPharma and MedTech Days, Nordic-American Life Science Conference 2020
View videos from the Nordic-American Life Science Conference 2020. See all three days for video links.
Keynote Address, Nordic Mentor Network for Entrepreneurship (NOME) 2019
Jonathan P. Gertler, MD provided the keynote address at the annual meeting of the Nordic Mentor Network for Entrepreneurship (NOME), 2019.